Jeff Yass’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
+890,949
New +$2.35M ﹤0.01% 6903
2026
Q1
Sell
-42,916
Closed -$105K 13781
2025
Q4
$83.7K Buy
+42,916
New +$70.4K ﹤0.01% 11550
2025
Q3
Sell
-147,497
Closed -$107K 13378
2025
Q2
$107K Buy
147,497
+80,204
+119% +$60.3K ﹤0.01% 11756
2025
Q1
$57.9K Buy
67,293
+28,289
+73% +$42K ﹤0.01% 11809
2024
Q4
$65.5K Buy
+39,004
New +$93.3K ﹤0.01% 11567
2024
Q1
Sell
-21,710
Closed -$64.9K 12932
2023
Q4
$64.9K Buy
+21,710
New +$62.1K ﹤0.01% 11596
2023
Q3
Sell
-42,445
Closed -$138K 12616
2023
Q2
$164K Sell
42,445
-54,921
-56% -$158K ﹤0.01% 10477
2023
Q1
$270K Buy
97,366
+73,548
+309% +$154K ﹤0.01% 9955
2022
Q4
$42.9K Sell
23,818
-13,352
-36% -$25.8K ﹤0.01% 11473
2022
Q3
$79K Sell
37,170
-87,047
-70% -$219K ﹤0.01% 11895
2022
Q2
$334K Sell
124,217
-55,378
-31% -$206K ﹤0.01% 9284
2022
Q1
$779K Buy
179,595
+21,343
+13% +$87.6K ﹤0.01% 7785
2021
Q4
$820K Sell
158,252
-55,593
-26% -$298K ﹤0.01% 7816
2021
Q3
$1.31M Buy
213,845
+187,309
+706% +$1.49M ﹤0.01% 6844
2021
Q2
$268K Buy
+26,536
New +$287K ﹤0.01% 11019

Other funds holding NAUT

Jeff Yass's NAUT Position: Q2 2026 in Review

Jeff Yass opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 890,949 shares worth $1.67M. The stake represents ﹤0.01% of the portfolio and ranks #6903 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NAUT as recently as Q4 2025.

Jeff Yass first reported a position in NAUT in Q2 2021 and has held it in 15 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Jeff Yass held 890,949 shares of Nautilus Biotechnolgy worth $1.67M as of Q2 2026.
  • Nautilus Biotechnolgy was a new Jeff Yass position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6903 holding.
  • Jeff Yass first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 15 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.